Skip to main content

Jublia News

FDA Approves Ortho Dermatologics' Labeling for Jublia (efinaconazole) Topical Solution, 10%, In Patients As Young As Six Years Old

LAVAL, Quebec, April 29, 2020 /PRNewswire/ – Bausch Health Companies Inc. (NYSE/TSX: BHC) and its dermatology business, Ortho Dermatologics, one of the largest prescription dermatology health care...

Ask a question

To post your own question to our community, sign in or create an account.

Further information

Jublia patient information at Drugs.com